Medicare Enrolled
Dr. Josep Genebriera De Lamo, M.D.
Student in an Organized Health Care Education/Training Program · Jacksonville, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Genebriera De Lamo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Genebriera De Lamo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Genebriera De Lamo
Dr. Josep Genebriera De Lamo is a student in an organized health care education/training program specialist in Jacksonville, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Genebriera De Lamo performed 12,944 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Genebriera De Lamo received a total of $175,366 from 44 pharmaceutical and/or device companies across 1485 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Genebriera De Lamo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in FL
$175,366 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,944
Medicare services
Top 1% in FL for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,847 | $5 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,209 | $60 | $318 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,257 | $34 | $245 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
1,063 | $63 | $380 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
802 | $78 | $420 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
730 | $85 | $446 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
381 | $39 | $189 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
259 | $1 | $4 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
191 | $225 | $1,113 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
160 | $72 | $393 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
150 | $97 | $891 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
120 | $129 | $702 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $111 | $582 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
86 | $125 | $617 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
81 | $190 | $978 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
79 | $10 | $51 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
63 | $67 | $634 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $40 | $201 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
44 | $55 | $355 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
34 | $300 | $1,175 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
33 | $112 | $1,009 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
30 | $34 | $207 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
25 | $60 | $577 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
23 | $101 | $919 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 20 | $140 | $756 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
18 | $74 | $551 |
| Destruction of cancerous skin growth on face, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 2.1 and 3.0 centimeters in diameter. |
16 | $188 | $871 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $96 | $472 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
14 | $238 | $1,139 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
14 | $218 | $1,074 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
12 | $362 | $1,719 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$175,366
Total received (2018-2024)
Avg $25,052/year across 7 years
Top 0% in FL for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,485
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,210
2023
$7,143
2022
$13,831
2021
$10,897
2020
$9,610
2019
$75,202
2018
$43,472
Payments by company (2024)
Galderma Laboratories, L.P.
$10,364
Dermavant Sciences, Inc.
$912
ABBVIE INC.
$673
Arcutis Biotherapeutics, Inc.
$524
Janssen Biotech, Inc.
$496
Novartis Pharmaceuticals Corporation
$397
GENZYME CORPORATION
$366
Regeneron Healthcare Solutions, Inc.
$276
SUN PHARMACEUTICAL INDUSTRIES INC.
$250
E.R. Squibb & Sons, L.L.C.
$229
Lilly USA, LLC
$148
UCB, Inc.
$148
Amgen Inc.
$108
PFIZER INC.
$95
Incyte Corporation
$93
MAYNE PHARMA COMMERCIAL LLC
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Ortho Dermatologics, a division of Bausch Health US, LLC
$17
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$112,995
ABBVIE INC.
$16,017
AbbVie Inc.
$15,686
Galderma Laboratories, L.P.
$11,147
GENZYME CORPORATION
$2,164
Janssen Biotech, Inc.
$2,021
Novartis Pharmaceuticals Corporation
$1,636
Dermavant Sciences, Inc.
$1,464
Mayne Pharma Inc.
$1,349
Regeneron Healthcare Solutions, Inc.
$1,259
LEO Pharma Inc.
$1,210
Lilly USA, LLC
$848
Amgen Inc.
$821
PFIZER INC.
$741
E.R. Squibb & Sons, L.L.C.
$740
Arcutis Biotherapeutics, Inc.
$702
UCB, Inc.
$611
Ortho Dermatologics, a division of Bausch Health US, LLC
$552
MAYNE PHARMA INC.
$443
Incyte Corporation
$413
Sun Pharmaceutical Industries Inc.
$409
SUN PHARMACEUTICAL INDUSTRIES INC.
$387
VYNE Pharmaceuticals Inc.
$199
Journey Medical Corporation
$159
Almirall LLC
$136
Celgene Corporation
$129
Allergan Inc.
$123
Encore Dermatology Inc.
$114
DERMIRA, INC.
$102
Sandoz Inc.
$96
Mylan Pharmaceuticals Inc.
$91
MAYNE PHARMA COMMERCIAL LLC
$89
Allergan, Inc.
$81
EPI Health, LLC
$79
PruGen, Inc. Pharmaceuticals
$52
Biofrontera Inc.
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$40
DUSA Pharmaceuticals, Inc.
$37
Taro Pharmaceuticals USA, Inc.
$33
Smith & Nephew, Inc.
$28
Genentech USA, Inc.
$27
Verrica Pharmaceuticals Inc.
$22
Promius Pharma LLC
$18
Top 3 companies account for 82.5% of all-time payments
Associated products mentioned in payments ›
0.25% · 20% · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · Exelderm · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · KERYDIN · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Santyl · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · TargaDox · Tremfya · Trianex · VTAMA · Winlevi · Xolair · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
1,071
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Genebriera De Lamo is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Genebriera De Lamo experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Genebriera De Lamo performed 4,847 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Genebriera De Lamo receive payments from pharmaceutical companies?
Yes. Dr. Genebriera De Lamo received a total of $175,366 from 44 companies across 1,485 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Genebriera De Lamo's costs compare to other student in an organized health care education/training programs in Jacksonville?
Dr. Genebriera De Lamo's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Genebriera De Lamo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Jacksonville
Browse student in an organized health care education/training programs in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in FL
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in FL
Which FL student in an organized health care education/training programs receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology